The delay in testing drugs like ivermectin to treat COVID-19 may be due to the economic incentive to develop vaccines, which provide a larger revenue stream than traditional drugs that require continual dosing. Some have questioned whether there is a conspiracy to suppress the use of ivermectin and other similar drugs.